Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma

British Journal of Haematology

Volumn 146, Issue 2, 2009, Pages 158-163

  Moskowitz, Alison J ^a   Perales, Miguel Angel ^a   Kewalramani, Tarun ^b   Yahalom, Joachim ^a   Castro Malaspina, Hugo ^a   Zhang, Zhigang ^a   Vanak, Jill ^a   Zelenetz, Andrew D ^a   Moskowitz, Craig H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Autologous stem cell transplant; Hodgkins lymphoma; Reduced intensity transplant; Relapse; Transplantation

Indexed keywords

CARBOPLATIN; CHLORMETHINE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; NAVELBINE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER GROWTH; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67649939212     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07727.x     Document Type: Article

References (16)

1. Baron, F., Storb, R., Storer, B.E., Maris, M.B., Niederwieser, D., Shizuru, J.A., Chauncey, T.R., Bruno, B., Forman, S.J., McSweeney, P.A., Maziarz, R.T., Pulsipher, M.A., Agura, E.D., Wade, J., Sorror, M., Maloney, D.G. Sandmaier, B.M. (2006) Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation. Journal of Clinical Oncology, 24, 4150 4157. (Pubitemid 46622292)
2. Duggan, D.B., Petroni, G.R., Johnson, J.L., Glick, J.H., Fisher, R.I., Connors, J.M., Canellos, G.P. Peterson, B.A. (2003) Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. Journal of Clinical Oncology, 21, 607 614. (Pubitemid 46621893)
3. Josting, A., Rueffer, U., Franklin, J., Sieber, M., Diehl, V. Engert, A. (2000) Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group. Blood, 96, 1280 1286. (Pubitemid 30658456)
4. Kewalramani, T., Nimer, S.D., Zelenetz, A.D., Malhotra, S., Qin, J., Yahalom, J. Moskowitz, C.H. (2003) Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma. Bone Marrow Transplantation, 32, 673 679. (Pubitemid 37258622)
5. Lavoie, J.C., Connors, J.M., Phillips, G.L., Reece, D.E., Barnett, M.J., Forrest, D.L., Gascoyne, R.D., Hogge, D.E., Nantel, S.H., Shepherd, J.D., Smith, C.A., Song, K.W., Sutherland, H.J., Toze, C.L., Voss, N.J.S. Nevill, T.J. (2005) High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver. Blood, 106, 1473 1478. (Pubitemid 41129618)
6. Linch, D.C., Winfield, D., Goldstone, A.H., Moir, D., Hancock, B., McMillan, A., Chopra, R., Milligan, D. Hudson, G.V. (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet, 341, 1051 1054. (Pubitemid 23114397)
7. Moskowitz, C.H., Bertino, J.R., Glassman, J.R., Hedrick, E.E., Hunte, S., Coady-Lyons, N., Agus, D.B., Goy, A., Jurcic, J., Noy, A., O'Brien, J., Portlock, C.S., Straus, D.S., Childs, B., Frank, R., Yahalom, J., Filippa, D., Louie, D., Nimer, S.D. Zelenetz, A.D. (1999) Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma. Journal of Clinical Oncology, 17, 3776 3785.
8. Moskowitz, C.H., Nimer, S.D., Zelenetz, A.D., Trippett, T., Hedrick, E.E., Filippa, D.A., Louie, D., Gonzales, M., Walits, J., Coady-Lyons, N., Qin, J., Frank, R., Bertino, J.R., Goy, A., Noy, A., O'Brien, J.P., Straus, D., Portlock, C.S. Yahalom, J. (2001) A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model. Blood, 97, 616 623. (Pubitemid 32113392)
9. Moskowitz, C., Yahalom, J., Zelenetz, A.D., Hamlin, P.A., Horwitz, S.M., Noy, A., Portlock, C.S., Straus, D.J., Kewalramani, T., Gerecitano, J., Vanak, J. Nimer, S.D. (2009) Risk-adapted high dose chemoradiotherapy and ASCT for patients with relapsed or refractory Hodgkin's disease: An intent to treat analysis (submitted).
10. Paltiel, O., Rubinstein, C., Or, R., Nagler, A., Gordon, L., Deutsch, L., Polliack, A. Naparstek, E. (2003) Factors associated with survival in patients with progressive disease following autologous transplant for lymphoma. Bone Marrow Transplantation, 31, 565 569. (Pubitemid 36546834)
11. Robinson, S.P., Sureda, A., Canals, C., Russell, N., Caballero, D., Bacigalupo, A., Iriondo, A., Cook, G., Pettitt, A., Socie, G., Bonifazi, F., Bosi, A., Michallet, M., Liakopoulou, E., Maertens, J., Passweg, J., Clarke, F., Martino, R., Schmitz, N. on behalf of the Lymphoma Working Party of the EBMT (2008) Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome. Haematologica, 94, 230 238.
12. Schmitz, N., Pfistner, B., Sextro, M., Sieber, M., Carella, A.M., Haenel, M., Boissevain, F., Zschaber, R., Muller, P., Kirchner, H., Lohri, A., Decker, S., Koch, B., Hasenclever, D., Goldstone, A.H. Diehl, V. (2002) Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. Lancet, 359, 2065 2071. (Pubitemid 34680969)
13. Schmitz, N., Dreger, P., Glass, B. Sureda, A. (2007) Allogeneic transplantation in lymphoma: current status. Haematologica, 92, 1533 1548. (Pubitemid 350144129)
14. Sureda, A., Arranz, R., Iriondo, A., Carreras, E., Lahuerta, J., García-Conde, J., Jarque, I., Caballero, M., Ferrà, C., López, A., García-Laraña, J., Cabrera, R., Carrera, D., Ruiz-Romero, M., León, A., Rifón, J., Díaz-Mediavilla, J., Mataix, R., Morey, M., Moraleda, J., Altés, A., López-Guillermo, A., de la Serna, J., Fernández-Rañada, J., Sierra, J. Conde, E. (2001) Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group. Journal of Clinical Oncology, 19, 1395 1404. (Pubitemid 32202546)
15. Thomson, K.J., Peggs, K.S., Smith, P., Cavet, J., Hunter, A., Parker, A., Pettengell, R., Milligan, D., Morris, E.C., Goldstone, A.H., Linch, D.C. Mackinnon, S. (2008) Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation. Bone Marrow Transplantation, 41, 765 770. (Pubitemid 351696339)
16. Vose, J.M., Bierman, P.J., Anderson, J.R., Kessinger, A., Pierson, J., Nelson, J., Frappier, B., Schmit-Pokorny, K., Weisenburger, D. Armitage, J.O. (1992) Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up. Blood, 80, 2142 2148.